Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience - Concepedia

Concepedia

Publication | Open Access

Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience

DOI Full Paper Access

41

Citations

29

References

2023

Year

Tucker Coston, Aakash Desai, Hani M. Babiker, Mohamad Bassam Sonbol, Sakti Chakrabarti, Amit Mahipal, Robert R. McWilliams, Wen Wee, Tanios Bekaii‐Saab, John Stauffer,

JCO Precision Oncology

Abstract

Our data argue for the preferential use of ICI over cytotoxic chemotherapy in any patient with dMMR/MSI-H PC requiring systemic therapy, including in the metastatic and adjuvant/neoadjuvant settings.

References

	Year	Citations

Page 1